Serum LAPTM4B as a Potential Diagnostic and Prognostic Biomarker for Breast Cancer

Table 4

Changes of serum LAPTM4B levels in BC patients before and after two cycles of adjuvant therapy (median (IQR)).

Group	Number	LAPTM4B (ng/mL)		value
		Before AT	After AT
Adjuvant therapy patients	46	11.06 (36.48)	7.25 (9.32)	0.001